Wellcome Trust’s Syncona Bets On Gene Therapy in Eye Disease

The profit-oriented evergreen fund of Britain’s charitable foundation The Wellcome Trust, Syncona, has invested £12 million in an academic spin-out to develop and commercialize therapies for treating degenerative eye diseases.

More from Europe

More from Geography